Author:
Hanxue Zheng,Zilu Meng,Liansheng Zhang,Lijuan Li
Funder
the National Natural Science Foundation of China
the Commissioned Project of National Clinical Medicine Research Center for Hematological System Diseases
the Clinical Medical Research Center of Hematological Diseases in Gansu Province
the Natural Science Foundation of Science and Technology Program of Gansu Province
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. El Chaer, F., Hourigan, C. S. & Zeidan, A. M. How I treat AML incorporating the updated classifications and guidelines. Blood 141, 2813–2823 (2023).
2. Pollyea, D. A. et al. Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 21, 503–513 (2023).
3. Thol, F., Döhner, H. & Ganser, A. How I treat refractory and relapsed acute myeloid leukemia. Blood 143, 11–20 (2024).
4. Bhansali, R. S., Pratz, K. W. & Lai, C. Recent advances in targeted therapies in acute myeloid leukemia. J. Hematol. Oncol. 16, 29 (2023).
5. Newell, L. F. & Cook, R. J. Advances in acute myeloid leukemia. BMJ 375, n2026 (2021).